Wegovy Dosing Guide (Canada)

semaglutideNovo Nordisk

WEGOVY® is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) with at least one weight-related comorbidity.

About this page. This page summarizes dosing information published by Health Canada in the product monograph for Wegovy. It is for informational purposes only and is not a substitute for advice from your prescriber or pharmacist. Always follow the dosing instructions provided to you by your healthcare provider. Read our full medical disclaimer →

Titration Schedule

Weeks 1–4
0.25 mg
once weekly
^{[1]Section 4.2, Table 2, page 9}
Weeks 5–8
0.5 mg
once weekly
^{[1]Section 4.2, Table 2, page 9}
Weeks 9–12
1 mg
once weekly
^{[1]Section 4.2, Table 2, page 9}
Weeks 13–16
1.7 mg
once weekly
^{[1]Section 4.2, Table 2, page 9}
Week 17+
2.4 mg
once weekly
Maintenance^{[1]Section 4.2, Table 2, page 9}
Therapeutic/maintenance dose.

If you miss a dose

If within 5 days

If a dose is missed and the next scheduled dose is at least 2 days (48 hours) away, administer WEGOVY® as soon as possible. Resume the once-weekly dosing schedule.

^{[2]Section 4.5, page 10}

If outside 5 days

If a dose is missed and the next scheduled dose is less than 2 days (48 hours) away, skip the missed dose. Resume the once-weekly dosing schedule.

^{[2]Section 4.5, page 10}

Talk to your pharmacist or prescriber

Dosing decisions — including when to adjust or maintain your dose — must be made with your prescriber or pharmacist. Use our pharmacy comparison tool to find and connect with a Canadian pharmacy that carries Wegovy.

Find a pharmacy near you

Sources

Last reviewed May 14, 2026 against the Health Canada Product Monograph dated December 10, 2025. View monograph →

Related information

Wegovy — Side Effects

/reference/side-effects/wegovy

Wegovy — Injection & Storage

/reference/injection-storage/wegovy